Pro-nociceptive action of cholecystokinin in the periaqueductal grey: A role in neuropathic and anxiety-induced hyperalgesic states

Neuroscience & Biobehavioral Reviews - Tập 32 - Trang 852-862 - 2008
T.A. Lovick1
1Department of Physiology, University of Birmingham, Birmingham, B15 2TT, UK

Tài liệu tham khảo

Abols, 1981, Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain–medullary interactions in the modulation of pain, Journal of Comparative Neurology, 201, 285, 10.1002/cne.902010211

Aloisi, 2006, Sex hormones, central nervous system and pain, Hormones and Behavior, 50, 1, 10.1016/j.yhbeh.2005.12.002

Andre, 2005, Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies, Journal of Neuroscience, 25, 7896, 10.1523/JNEUROSCI.0743-05.2005

Arnér, 1988, Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain, Pain, 33, 11, 10.1016/0304-3959(88)90198-4

Bajaj, 2001, Sensory changes during the ovulatory phase of the menstrual cycle in healthy women, European Journal of Pain, 5, 135, 10.1053/eujp.2001.0236

Ballaz, 2007, The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence, Neuroscience Letters, 428, 27, 10.1016/j.neulet.2007.09.035

Bee, 2007, Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states, Neuroscience, 147, 786, 10.1016/j.neuroscience.2007.05.004

Beitz, 1983, The periaqueductal gray-raphe magnus projection contains somatostatin, neurotensin and serotonin but not cholecystokinin, Brain Research, 261, 132, 10.1016/0006-8993(83)91292-1

Benedetti, 2007, Placebo and endogenous mechanisms of analgesia, Handbook of Experimental Pharmacology, 177, 393, 10.1007/978-3-540-33823-9_14

Benedetti, 2006, The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect, Journal of Neuroscience, 26, 12014, 10.1523/JNEUROSCI.2947-06.2006

Benedetti, 2007, When words are painful: unravelling the mechanisms of the nocebo effect, Neurocience, 147, 260, 10.1016/j.neuroscience.2007.02.020

Berna1, 2007, Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential, Current Opinion in Pharmacology, 7, 583, 10.1016/j.coph.2007.09.011

Bernal, 2007, PAG mu opioid receptor activation underlies sex differences in morphine antinociception, Behavioral Brain Research, 177, 126, 10.1016/j.bbr.2006.10.028

Bertoglio, 2005, Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats, Brain Research, 1059, 46, 10.1016/j.brainres.2005.08.006

Brack, 2007, Neuronal excitability in the periaqueductal grey matter during the oestrous cycle in female rats, Neuroscience, 144, 325, 10.1016/j.neuroscience.2006.08.058

Bradwejn, 1994, The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder, Archives of General Psychiatry, 51, 486, 10.1001/archpsyc.1994.03950060050005

Carlson, 2007, Sensitization of pain-modulating neurons in the rostral ventromedial medulla after peripheral nerve injury, Journal of Neuroscience, 27, 1322, 10.1523/JNEUROSCI.3715-07.2007

Chen, 2006, Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse, Proceedings of the National Academy of Sciences USA, 103, 3881, 10.1073/pnas.0505407103

Commons, 2000, Presynaptic and postsynaptic relations of mu-opioid receptors to gamma-aminobutyric acid-immunoreactive and medullary-projecting periaqueductal gray neurons, Journal of Comparative Neurology, 419, 532, 10.1002/(SICI)1096-9861(20000417)419:4<532::AID-CNE8>3.0.CO;2-6

Coudoré-Civiale, 2000, Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats, Pain, 88, 15, 10.1016/S0304-3959(00)00304-3

Deng, 2006, Bi-directional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats, Journal of Physiology, 572, 425, 10.1113/jphysiol.2005.104463

Dickenson, 1987, Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation, Neuropharmacology, 26, 1235, 10.1016/0028-3908(87)90275-9

Dourish, 1990, The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat, European Journal of Pharmacology, 176, 35, 10.1016/0014-2999(90)90129-T

Erel, 2004, Increased cholecystokinin release in the rat anterior cingulae cortex during carrageenan-induced arthritis, Brain Research, 1022, 39, 10.1016/j.brainres.2004.05.087

Fairhurst, 2007, Anticipatory brainstem activity predicts neural processing of pain in humans, Pain, 128, 101, 10.1016/j.pain.2006.09.001

Farook, 2004, Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague–Dawley rats using elevated plus-maze test apparatus, Neuroscience Letters, 358, 215, 10.1016/j.neulet.2004.01.027

Fillingim, 2000, Sex-related hormonal influences on pain and analgesic responses, Neuroscience and Biobehavioral Reviews, 24, 485, 10.1016/S0149-7634(00)00017-8

Floyd, 2000, Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat, Journal of Comparative Neurology, 422, 556, 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U

Gebhart, 2004, Descending modulation of pain, Neuroscience and Biobehavioral Reviews, 27, 729, 10.1016/j.neubiorev.2003.11.008

Geerse, 2006, Individual reactivity to the open-field predicts the expression of stress-indiced behavioural and somatic pain sensitisation, Behavioral Brain Research, 174, 112, 10.1016/j.bbr.2006.07.010

Griffiths, 2005, Withdrawal from progesterone increases expression of α4, β1 and δ GABAA receptor subunits in neurones in the periaqueductal grey matter in female Wistar rats, Journal of Comparative Neurology, 486, 89, 10.1002/cne.20540

Griffiths, 2005, GABAergic neurones in the rat periaqueductal grey matter express α4, β1 and δ GABAA receptor subunits: plasticity of expression during the estrous cycle, Neuroscience, 136, 457, 10.1016/j.neuroscience.2005.08.013

Gustafsson, 1998, Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn—possible involvement of cholecystokinin-B receptors, Brain Research, 790, 141, 10.1016/S0006-8993(98)00060-2

Hahm, 2004, Opioid inhibition of GABAergic neurotransmission in mechanically isolated rat periaqueductal gray neurons, Neuroscience Research, 50, 343, 10.1016/j.neures.2004.03.005

Hardy, 1986, Projections to the midbrain from the medial versus lateral prefrontal cortices of the rat, Neuroscience Letters, 63, 159, 10.1016/0304-3940(86)90054-6

Hart, 2001, Quantitative analysis of ER alpha and GAD colocalization in the hippocampus of the adult female rat, Journal of Comparative Neurology, 440, 144, 10.1002/cne.1376

Hayes, 1978, Behavioral and physiological studies of non-narcotic analgesia in the rat elicited by certain environmental stimuli, Brain Research, 155, 69, 10.1016/0006-8993(78)90306-2

Heinricher, 2005, Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla, Journal of Neurophysiology, 92, 1982, 10.1152/jn.00411.2004

Heinricher, 2004, Prostaglandin E2 in the midbrain periaqueductal gray produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla, Pain, 110, 419, 10.1016/j.pain.2004.04.026

Hilke, 2007, Cholecystokinin levels in the rat brain during the estrous cycle, Brain Research, 1144, 70, 10.1016/j.brainres.2007.01.107

Hösing, 2004, Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder, Journal of Neural Transmission, 68, 147, 10.1007/978-3-7091-0579-5_17

Houghton, 2002, The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers, Gut, 50, 471, 10.1136/gut.50.4.471

Hruby, 2003, Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain, Life Science, 73, 699, 10.1016/S0024-3205(03)00390-4

Ise, 2003, Association between the CCK-A receptor gene and panic disorder, American Journal of Medical Genetics B: Neuropsychiatric Genetics, 118, 29, 10.1002/ajmg.b.10020

Jones, 1988, Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: activation of descending inhibition by morphine, glutamate and electrical stimulation, Brain Research, 460, 281, 10.1016/0006-8993(88)90373-3

Jørum, 1988, Analgesia or hyperalgesia following stress correlates with emotional behavior in rats, Pain, 32, 341, 10.1016/0304-3959(88)90046-2

Kain, 2000, Preoperative anxiety and postoperative pain in women undergoing hysterectomy. A repeated-measures design, Journal of Psychosomatic Research, 49, 417, 10.1016/S0022-3999(00)00189-6

Kamei, 2001, The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice, Brain Research, 892, 370, 10.1016/S0006-8993(00)03273-X

Kõks, 2000, Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations, Journal of Psychiatry and Neuroscience, 25, 33

Kombian, 2004, Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro, Journal of Physiology, 555, 71, 10.1113/jphysiol.2003.056739

Kombian, 2005, Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors, Journal of Neuroscience Research, 79, 412, 10.1002/jnr.20349

Koshi, 2007, Placebo theory and its implications for research and clinical practice: a review of the recent literature, Pain Practice, 7, 4, 10.1111/j.1533-2500.2007.00104.x

Kovelowski, 2000, Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat, Pain, 87, 265, 10.1016/S0304-3959(00)00290-6

Kubota, 1983, The distribution of cholecystokinin octapeptide-like structures in the lower brainstem of the rat: an immunohistochemical analysis, Neuroscience, 9, 587, 10.1016/0306-4522(83)90176-8

Kurrikoff, 2004, Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice, European Journal of Neuroscience, 20, 1577, 10.1111/j.1460-9568.2004.03619.x

Lautenbacher, 1999, Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder, Psychosomatic Medicine, 61, 822, 10.1097/00006842-199911000-00015

LeMelledo, 1998, Neuropsychopharmacology, 20, 81, 10.1016/S0893-133X(98)00057-8

Li, 1989, Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat, Brain Research, 480, 105, 10.1016/0006-8993(89)91572-2

Liu, 1994, Characterization of the effect of cholecytokinin (CCK) on neurons in the periaqueductal gray of the that: immunocytochemical and in vivo and in vitro electrophysiological studies, Brain Research, 642, 83, 10.1016/0006-8993(94)90908-3

Loivck, 1996, Midbrain and medullary regulation of defensive cardiovascular functions, Progress in Brain Research, 107, 301, 10.1016/S0079-6123(08)61872-5

Lovick, 2005, Changes in GABA(A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats, Neuroscience, 131, 397, 10.1016/j.neuroscience.2004.11.010

Ma, 2006, Modulatory effect of CCK-8S on GABA-induced depolarization from rat dorsal root ganglion, Brain Research, 1121, 66, 10.1016/j.brainres.2006.08.094

Maron, 2004, The effect of 5-hydroxytryptophan on chlolecystokinin-4-induced panic attacks inhealthy cvolunteers, Journal of Psychopharmacology, 18, 194, 10.1177/0269881104042619

Mercer, 2004, Immunolocalization of CCK1R in rat brain using a new anti-peptide antibody, Neuroscience Letters, 359, 109, 10.1016/j.neulet.2004.01.045

Mercer, 1996, On the distribution of cholecystokinin B receptors in monkey brain, Brain Research, 738, 313, 10.1016/S0006-8993(96)00477-5

Mercer, 2000, Direct visualisation of cholecystokinin subtye2 receptors in rat central nervous system using anti-peptide antibodies, Neuroscience Letters, 293, 167, 10.1016/S0304-3940(00)01504-4

Micevych, 1996, Induction of CCK mRNA levels in the limbic-hypothalamic circuit: time course and site-specific effects of estrogen, Journal of Neurobiology, 30, 465, 10.1002/(SICI)1097-4695(199608)30:4<465::AID-NEU3>3.0.CO;2-1

Micevych, 1988, Concentrations of cholecystokinin, substance P and bombesin ion discrete regions of male and female rat brain: sex differences and estrogen effects, Experimental Neurology, 100, 416, 10.1016/0014-4886(88)90119-7

Miranda-Paiva, 2003, A role for the periaqueductal gray in opioidergic inhibition of maternal behavior, European Journal of Neuroscience, 18, 667, 10.1046/j.1460-9568.2003.02794.x

Miranda-Paiva, 2007, Periaqueductal gray cholecystokinin infusions block morphine-induced disruption of maternal behavior, Peptides, 28, 657, 10.1016/j.peptides.2006.11.005

Mouton, 1998, Three times as many lamina I neurons project to the periaqueductal gray than to the thalamus: a retrograde tracing study in the cat, Neuroscience Letters, 255, 107, 10.1016/S0304-3940(98)00723-X

Netto, 2004, Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray, Neuropsychopharmacology, 29, 101, 10.1038/sj.npp.1300334

Nitschke, 2006, Functional neuroanatomy of aversion and its anticipation, Neuroimage, 29, 106, 10.1016/j.neuroimage.2005.06.068

Noble, 1999, International Union of Pharmacology XXI. Structure, distributions and functions of cholecystokinin receptors, Pharmcological Reviews, 51, 745

Nelovkov, 2006, Rats displaying distinct exploratory activity also have different expression patterns of γ-aminobutyric acid- and cholecystokinin-related genes in brain regions, Brain Research, 1100, 71, 10.1016/j.brainres.2006.05.007

Ogawa, 1994, In vitro electrophysiological characterization of midbrain periaqueductal gray neurons in female rats: responses to GABA- and Met-enkephalin-related agents, Brain Research, 666, 239, 10.1016/0006-8993(94)90778-1

Pertovaara, 1996, Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats, Neuroscience Letters, 218, 127, 10.1016/S0304-3940(96)13136-0

Pleym, 2003, Gender differences in drug effects: implications for anesthesiologists, Acta Anaesthesiologica Scandinavica, 47, 241, 10.1034/j.1399-6576.2003.00036.x

Pommier, 2002, Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system, Journal of Neuroscience, 22, 2005, 10.1523/JNEUROSCI.22-05-02005.2002

Powell-Boone, 2005, Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis, Journal of Urology, 174, 1832, 10.1097/01.ju.0000176747.40242.3d

Quintero, 2000, Long lasting delayed hyperalgesia after subchronic swim stress, Pharmacology Biochemistry and Behavior, 67, 449, 10.1016/S0091-3057(00)00374-9

Rattray, 1987, Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone, Neuropeptides, 10, 189, 10.1016/0143-4179(87)90021-7

Renno, 1992, Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat, Brain Research, 594, 221, 10.1016/0006-8993(92)91129-3

Rhudy, 2005, Gender differences in pain: do emotions play a role?, Gender Medicine, 2, 208, 10.1016/S1550-8579(05)80051-8

Riley, 1999, A meta-analytic review of pain perception across the menstrual cycle, Pain, 81, 225, 10.1016/S0304-3959(98)00258-9

Rodgers, 1995, Cholecystokinin and anxiety: promises and pitfalls, Critical Review of Neurobiology, 9, 345

Rudick, 2001, Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat, Journal of Neuroscience, 21, 6532, 10.1523/JNEUROSCI.21-17-06532.2001

Shane, 2007, Estrus phase differences in female rats in morphine antinociception elicited from the ventrolateral periaqueductal gray, International Journal of Neuroscience, 117, 811, 10.1080/00207450600910259

Skinner, 1997, Cholecystokinin and enkephalin in brain stem pain modulating circuits, Neuroreport, 8, 2995, 10.1097/00001756-199709290-00001

Simpson, 2001, Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety, Proceedings of the National Academy of Sciences USA, 98, 688, 10.1073/pnas.98.2.688

Smith, 1998, Withdrawal from 3α-OH-5α pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor α4 subunit in association with increased anxiety, Journal of Neuroscience, 18, 5275, 10.1523/JNEUROSCI.18-14-05275.1998

Steiner, 1997, Premenstrual syndromes, Annual Review of Medicine, 48, 447, 10.1146/annurev.med.48.1.447

Stiller, 1996, Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving rats, Neuroscience Letters, 209, 165, 10.1016/0304-3940(96)12638-0

Sukikara, 2006, A role for the periaqueductal gray in switching adaptive behavioral responses, Journal of Neuroscience, 26, 2583, 10.1523/JNEUROSCI.4279-05.2006

Taenzer, 1986, Influence of psychological factors on postoperative pain, mood and analgesic requirements, Pain, 24, 331, 10.1016/0304-3959(86)90119-3

Tillu, D.V., Gebhart, G.F., Sluka, K.A., 2007. Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult. Pain, in press, doi:10.1016/j.pain.2007.07.011.

Tortorici, 2003, Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats, Pain, 102, 9, 10.1016/s0304-3959(02)00153-7

Urban, 1996, Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil, Brain Research, 737, 83, 10.1016/0006-8993(96)00631-2

Urch, 2005, Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology, Journal of Pain, 61, 837, 10.1016/j.jpain.2005.08.005

Van Megan, 1996, Cholecystokinin in anxiety, European Neuropsychopharmacology, 6, 263, 10.1016/S0924-977X(96)00038-7

VanderHorst, 2005, Estrogen receptor-α and -β immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems, Journal of Comparative Neurology, 488, 152, 10.1002/cne.20569

Vanegas, 2004, Descending control of persistent pain: inhibitory or facilitatory?, Brain Research Reviews, 46, 295, 10.1016/j.brainresrev.2004.07.004

Vaughan, 1997, How opioids inhibit GABA-mediated neurotransmission, Nature, 390, 611, 10.1038/37610

Vera-Portocarrero, 2006, Descending facilitation from the ventromedial medulla maintains visceral pain in rats with experimental pancreatitis, Gastroenterology, 130, 155, 10.1053/j.gastro.2006.03.025

Vera-Portocarrero, 2006, Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization, Neuroscience, 140, 1311, 10.1016/j.neuroscience.2006.03.016

Vidal, 1982, Stress hyperalgesia in rats: an experimental animal model of anxiogenic hyperalgesia in human, Life Science, 31, 1241, 10.1016/0024-3205(82)90352-6

Xie, 2005, Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance, Journal of Neuroscience, 25, 409, 10.1523/JNEUROSCI.4054-04.2005

Wang, 2005, Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats, Neuroscience and Biobehavioral Reviews, 29, 1361, 10.1016/j.neubiorev.2005.05.008

Watanabe, 1990, Dynamics of ovarian inhibin secretion during the oestrous cycle of the rat, Journal of Endocrinology, 126, 151, 10.1677/joe.0.1260151

Watkins, 1985, Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide, Brain Research, 327, 169, 10.1016/0006-8993(85)91511-2

Wiesenfeld-Hallin, 2005, Sex differences in pain perception, Gender Medicine, 2, 137, 10.1016/S1550-8579(05)80042-7

Wiesenfeld-Hallin, 1997, Central inhibitory dysfunctions: mechanisms and clinical implications, Behavioral and Brain Sciences, 20, 420, 10.1017/S0140525X97261480

Wiklund, 1988, Autoradiographic and electrophysiological evidence for excitatory amino acid transmission in the periaqueductal gray projection to nucleus raphe magnus in the rat, Neuroscience Letters, 93, 158, 10.1016/0304-3940(88)90074-2

Xu, 2001, Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behaviour in spinally injured rats, Peptides, 22, 1305, 10.1016/S0196-9781(01)00456-9

Yamamoto, 1995, Role of cholecystokinin-B receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat, Neuroscience Letters, 202, 89, 10.1016/0304-3940(95)12213-3

Yang, 2006, Cellular action of cholecystokinin-8S-mediated excitatory effects in the rat periaqueductal gray, Life Science, 79, 1702, 10.1016/j.lfs.2006.05.027

Yang, 2007, Cholecystokinin-8S-induced intracellular calcium signaling in acutely isolated periaqueductal gray neurons of the rat, Biological Pharmaceutical Bulletin, 30, 297, 10.1248/bpb.30.297

Zanovelli, 2004, Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze, Peptides, 25, 1935, 10.1016/j.peptides.2004.06.016

Zhang, 1997, Inhibitory effects of electrically evoked activation of ventrolateral orbital cortex on the tail-flick reflex are mediated by periaqueductal gray in rats, Pain, 72, 127, 10.1016/S0304-3959(97)00025-0

Zwanzinger, 2001, Vigabtrin decreased cholecystokinin-tetrapeptide (CCK-4)-induced panic in healthy volunteers, Neuropsychopharmacol, 25, 699, 10.1016/S0893-133X(01)00266-4

Thông tin
Thông tin xuất bản

Neuroscience & Biobehavioral Reviews

Tập 32

852-862

Thông tin tác giả